Heyholder

KMPHARMACEUTICAL Co.,Ltd. Disclosures

225430 · KOSDAQ

Disclosures

2 total · 20 per page

Newest first

Periodic Report

KM Pharmaceutical sold KRW 4.0 billion in Q3 and lost KRW 0.5 billion from its main business; sales fell 8.0% from a year earlier.

Catch the next disclosure fast

Get app alerts for new disclosures from KMPHARMACEUTICAL Co.,Ltd..